Creative Biolabs Accelerates Metabolic Disease Research with Comprehensive GLP-1R, ACACA, and IRS2 Antibody Portfolios
Creative Biolabs has announced the expansion of its extensively validated antibody catalog targeting critical nodes in metabolic regulation. SHIRLEY, NY, UNITED STATES, March 11, 2026 /EINPresswire.com/ -- The global biopharmaceutical sector …